Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?
- PMID: 81415
- DOI: 10.1016/s0140-6736(78)91573-8
Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?
Abstract
It is suggested that patients with the haemolytic-uraemic syndrome and related disorders (such as thrombotic thrombocytopenic purpura) lack a plasma factor which stimulates prostacyclin (P.G.I2) activity. Normal plasma would supply the missing factor and is a rational treatment for some life-threatening symptoms (thrombocytopenia, haemolytic anaemia, hypertension) of this syndrome.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources